Search

Search Constraints

You searched for: Author/Creator author non-byline. Issue Volume 12:Issue 2(2022)

Search Results

1. Assessment of the Cow's Milk-related Symptom Score (CoMiSS) as a diagnostic tool for cow's milk protein allergy: a prospective, multicentre study in China (MOSAIC study). Issue 2 (17th February 2022)

2. Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands. Issue 2 (28th February 2022)

3. Body composition and chemotherapy toxicity in women with early breast cancer (CANDO-3): protocol for an observational cohort study. Issue 2 (22nd February 2022)

4. Changes to postdiagnostic dementia support in England and Wales during the COVID-19 pandemic: a qualitative study. Issue 2 (2nd February 2022)

5. Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study. Issue 2 (8th February 2022)

6. Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London. Issue 2 (8th February 2022)

7. Development of support material for health professionals who are implementing Shared Decision-making in breast cancer screening: validation using the Delphi technique. Issue 2 (1st February 2022)

8. Identification of the optimal treatment strategy for complex appendicitis in the paediatric population: a protocol for a multicentre prospective cohort study (CAPP study). Issue 2 (17th February 2022)

9. Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ. Issue 2 (11th February 2022)

10. Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study. Issue 2 (15th February 2022)